CiteFacts · FDA Drug Shortages · FDA source
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-17) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-37) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-17) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31) | Unavailable | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-37) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57) | Available | 08/04/2026 |
| Fresenius Kabi USA, LLC | Sensorcaine, Injection, 7.5 mg/1 mL; .005 mg/1 mL (NDC 63323-460-37) | Available | 08/04/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride And Epinephrine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-9042-01) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-9046-01) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride And Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-9045-01) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride And Epinephrine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-9042-17) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride and Epinephrine, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-9043-01) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Bupivacaine Hydrochloride and Epinephrine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-9045-17) | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000) (NDC 0409-1752-50) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000) (NDC 0409-1749-29) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-10) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000) (NDC 0409-1755-50) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000) (NDC 0409-1749-10) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Marcaine With Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-30) | Available | 08/07/2026 |
Source facts
Grouped generic ingredient: Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection · 20 package records · Latest FDA row update: 08/07/2026
Therapeutic categories: Anesthesia
Dosage forms: Injection
Routes: EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL, RETROBULBAR
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.